Learn Suttons Creek’s StoryMeet Our Combination Product Specialists
Trust in Our 650+ Combined Years of Device and Combination Product Experience
We’ve successfully supported the development of over 60 individual drug and biologic delivery systems, covering a variety of systems including:
Auto Injectors, Pre-Filled Syringes, On-Body Devices, Inhalers, Lyo-Kits, Attached Bio-Sensors, Vial Adaptors, Adherence Support, Predictive Modeling Platforms.
Our specialists have proven credibility after leading 50+ big and small Pharma companies to global combination product success, and we can help you launch yours.
Having engaged with pharma since before the FDA’s combination product ruling, Suttons Creek, Inc. is uniquely positioned to be the industry’s premier device and connectivity team. With a roster of globally experienced, specialized consultants, Suttons Creek supports clients from concept to deployment through the complex regulatory approval process.
Our Team is Your Team
The Suttons Creek Executive Group
Meet the leadership of Suttons Creek. They set strategies and manage teams of talented combination product experts, hand-selected to provide the specialty subject matter expertise needed to make your project a success and support your corporate goals.
Suttons Creek, Inc.: Founded in 2012 by Steve Badelt, PhD.
Steve’s 20+ years of system engineering and medical device experience coupled with his genuine curiosity and interest in creating viable solutions to unique problems put him in an exceptional position to fulfill the new need in the pharmaceutical industry around combination products and software as a medical device. Throughout his career Steve fostered professional relationships with exceptional consultants in the Medical Device and Connectivity space with diverse backgrounds from aerospace to commercial product development, from defense to petroleum.
Suttons Creek is a member of the following industry organizations, providing us numerous opportunities to continually build upon our knowledge-base and industry relationships, as well as affect change in the regulatory landscape for combination products.